Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMelanoma and related topics, including MedlinePlus Genetics, were removed from the related topics section on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedMelanoma-related topics and MedlinePlus Genetics links were added, and the Locations section was updated with expanded country-level entries. Several location listings were removed, and the HHS Vulnerability Disclosure page was deleted.SummaryDifference2%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedMelanoma and related topics were removed from the page content. This reduces disease-specific context and related resource links on the study page.SummaryDifference0.1%

- Check42 days agoChange DetectedThe Publications section wording has been updated to indicate PubMed publications are auto-filled and may not all pertain to the study, and the revision banner shows Revision: v3.3.2 (from v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedA funding/operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedOnly minor visual/layout adjustments were observed; no core study information such as the title, brief summary, inclusion/exclusion criteria, endpoints, or locations appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.